Day One Biopharmaceuticals
Earnings Surprise
Analysts estimated DAWN earnings of $-0.15 per share this quarter (Q4). DAWN's actual earnings were $-0.21 per share.
DAWN EPS surprise of -35.57%Analysts estimated DAWN earnings of $-0.30 per share this quarter (Q3). DAWN's actual earnings were $-0.19 per share.
DAWN EPS surprise of 36.37%Analysts estimated DAWN earnings of $-0.36 per share this quarter (Q2). DAWN's actual earnings were $-0.29 per share.
DAWN EPS surprise of 20.33%Analysts estimated DAWN earnings of $-0.45 per share this quarter (Q1). DAWN's actual earnings were $-0.35 per share.
DAWN EPS surprise of 22.46%Analysts estimated DAWN earnings of $-0.37 per share this quarter (Q4). DAWN's actual earnings were $-0.64 per share.
DAWN EPS surprise of -73.35%Analysts estimated DAWN earnings of $-0.42 per share this quarter (Q3). DAWN's actual earnings were $-0.37 per share.
DAWN EPS surprise of 11.53%Analysts estimated DAWN earnings of $-0.77 per share this quarter (Q2). DAWN's actual earnings were $-0.05 per share.
DAWN EPS surprise of 93.47%Analysts estimated DAWN earnings of $-0.68 per share this quarter (Q1). DAWN's actual earnings were $-0.72 per share.
DAWN EPS surprise of -6.41%Analysts estimated DAWN earnings of $-0.59 per share this quarter (Q4). DAWN's actual earnings were $-0.64 per share.
DAWN EPS surprise of 7.56%